Search All News
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
- September 29, 2021
Just 17 when diagnosed with advanced cervical cancer, Sheneque Hanse is now in remission after two years of treatment and eager to start a career in health care to help others with cancer.
- September 9, 2021
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.
- September 3, 2021
Yoon, a surgical oncologist expert in the treatment of gastric cancer, sarcoma, and melanoma, is also the new vice chair of surgical oncology research and education in the Department of Surgery.
- July 26, 2021
A new robotic device from researchers at VP&S and Columbia Engineering could help guide recovery after treatment for head and neck cancer.
- July 9, 2021
A new brain cancer study is testing an ultrasound technology developed at Columbia to determine if the technology can open the blood-brain barrier and improve delivery of chemotherapy.
- July 1, 2021
Even a brief exposure to addictive medications for surgery-related pain or anxiety can lead to long-term use, a study by Columbia researchers has found.
- June 22, 2021
New guidelines encourage initial screening for colorectal cancer at 45 instead of 50, because younger people are increasingly being diagnosed with the disease, says Columbia's James Church, MD.
- June 9, 2021
Opinions vary about how to treat DCIS (ductal carcinoma in situ), but a new study suggests the optimal treatment for most women with this non-invasive breast cancer is surgery plus radiation.
- June 8, 2021
Results from a phase 2 clinical trial led by Columbia cancer researchers suggest that a combination of two drugs has potential to improve treatment of uterine leiomyosarcoma.